How Vaccines Work
1. Quick Summary
Your immune system can learn. The first time it meets a virus or bacterium, mounting a defence takes days, and that delay is often the difference between a mild illness and a serious one. A vaccine delivers a harmless version of the pathogen, or a recognisable piece of it, so the learning happens without the disease.
What is left afterwards is memory: long-lived cells that recognise that specific invader and can respond within hours instead of days. Vaccination is therefore not a drug that fights an infection. It is preparation that has to happen before the infection arrives.
2. What It Means
The adaptive immune system works by recognition. Cells called antigen-presenting cells break a pathogen into fragments and display them, and lymphocytes whose receptors happen to fit that fragment are activated and multiply. Two arms result: B cells produce antibodies that bind to the pathogen and block or tag it, and T cells either kill infected cells or coordinate the response.
Most of those activated cells die off once the threat is cleared. A small fraction persist as memory B and T cells, sometimes for decades. They carry the same receptor that worked the first time, so a second encounter is recognised almost immediately and the response starts from a much higher baseline.
A vaccine is anything that triggers this process safely. Classical vaccines use a weakened or killed pathogen. Subunit vaccines use only a protein from the surface. Viral vector vaccines use a harmless carrier virus to deliver instructions for one protein. mRNA vaccines deliver the same instructions as a short-lived strand of RNA that your cells read for a day or two before breaking it down.
3. Why It Happens
The immune system responds to shape, not to identity. It does not need the whole organism, only the part that antibodies can grip, which is usually a surface protein. That is why a vaccine can be built from one protein, or from instructions to make one protein, without any infectious organism being involved.
Adjuvants exist because a purified protein on its own is often too quiet. The innate immune system needs a danger signal before it takes a fragment seriously, so vaccines frequently include a substance that supplies one. Aluminium salts have been used for decades for exactly this purpose.
Boosters follow from how antibody levels behave. Concentrations peak after vaccination and then decline, which is expected and not a failure. Memory cells persist underneath, so a later dose, or a later exposure to the real pathogen, produces a rapid rise rather than a slow primary response. Boosters are timed to keep the circulating antibody level high in the people who need it most.
Population-level protection is arithmetic. If each infected person infects fewer than one other person on average, an outbreak shrinks. The fraction of a population that needs to be immune to reach that point depends on how transmissible the pathogen is, which is why the threshold differs so much between diseases.
4. Real Examples
Smallpox is the clearest demonstration. Because the virus had no animal reservoir and infection or vaccination produced lasting immunity, a sustained global campaign achieved eradication, with the last natural case in the 1970s.
Influenza shows the opposite case. The virus changes its surface proteins continually, so the memory built against last year’s strain recognises this year’s strain only partially. That is why the vaccine is reformulated annually rather than given once.
Tetanus illustrates why some vaccines need periodic boosters even though the disease is not spreading. The vaccine targets a toxin produced by the bacterium rather than the bacterium itself, and protection against that toxin fades over roughly a decade.
5. How It Affects Us
Vaccines shift risk rather than removing it, and the trade is usually steep. The common side effects, such as a sore arm or a day of fever, reflect the immune response being triggered, which is the intended effect. Serious reactions are rare enough that they are monitored through dedicated reporting systems rather than detected in trials.
The timing matters more than most people expect. Protection is not instant: building the response takes one to two weeks, so vaccination after exposure helps only for diseases with a long enough incubation period.
For individual decisions the reliable guidance remains the published schedule of your national health authority, since it reflects local disease patterns and the evidence for each specific vaccine. This article describes the mechanism, not a recommendation.
6. Key Takeaways
- Vaccines train the immune system in advance, converting a slow first response into a fast recall response.
- Only a recognisable fragment of the pathogen is needed, which is why modern vaccines can use one protein or instructions for one.
- Falling antibody levels are expected; memory cells persist and are the reason boosters work quickly.
- The protection threshold differs by disease because it depends on how transmissible the pathogen is.